BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mullen JT, Kwak EL, Hong TS. What's the Best Way to Treat GE Junction Tumors? Approach Like Gastric Cancer. Ann Surg Oncol 2016;23:3780-5. [PMID: 27459983 DOI: 10.1245/s10434-016-5426-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Blank S, Schmidt T, Heger P, Strowitzki MJ, Sisic L, Heger U, Nienhueser H, Haag GM, Bruckner T, Mihaljevic AL, Ott K, Büchler MW, Ulrich A. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach? Gastric Cancer 2018;21:303-14. [DOI: 10.1007/s10120-017-0746-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
2 Tanabe K, Saeki Y, Ohta H, Ohdan H. Successful robotic proximal gastrectomy with side overlap esophagogastrostomy following preoperative chemotherapy: A case report. International Journal of Surgery Case Reports 2022;94:107040. [DOI: 10.1016/j.ijscr.2022.107040] [Reference Citation Analysis]
3 Friedel D, Zhang X, Stavropoulos SN. Burgeoning study of sentinel-node analysis on management of early gastric cancer after endoscopic submucosal dissection. World J Gastrointest Endosc 2020; 12(4): 119-127 [PMID: 32341748 DOI: 10.4253/wjge.v12.i4.119] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jain S, Dhingra S. Pathology of esophageal cancer and Barrett's esophagus. Ann Cardiothorac Surg. 2017;6:99-109. [PMID: 28446998 DOI: 10.21037/acs.2017.03.06] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
5 Munitiz V, Ortiz A, Ruiz de Angulo D, F Martinez de Haro L, Parrilla P. Results of the different surgical options for the treatment of cancer of the esophagogastric junction: Review of the evidence. Cir Esp (Engl Ed) 2019;97:445-50. [PMID: 31027834 DOI: 10.1016/j.ciresp.2019.03.005] [Reference Citation Analysis]
6 Voron T, Gronnier C, Pasquer A, Thereaux J, Gagniere J, Lebreton G, Meunier B, Collet D, Piessen G, Paye F; FREGAT working group - FRENCH. Adenocarcinoma of the oesophagogastric junction Siewert II: An oesophageal cancer better cured with total gastrectomy. Eur J Surg Oncol 2019;45:2473-81. [PMID: 31350076 DOI: 10.1016/j.ejso.2019.07.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Xu J, Cao J, Wang L, Wang Z, Wang Y, Wu Y, Lv W, Hu J. Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction. Sci Rep. 2017;7:10123. [PMID: 28860457 DOI: 10.1038/s41598-017-09625-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
8 Lai S, Su T, He X, Lin Z, Chen S. Prognostic value of resected lymph nodes numbers for Siewert II gastroesophageal junction cancer. Oncotarget 2018;9:2797-809. [PMID: 29416812 DOI: 10.18632/oncotarget.23540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Hu C, Zhu HT, Xu ZY, Yu JF, Du YA, Huang L, Yu PF, Wang LJ, Cheng XD. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option. J Int Med Res 2019;47:398-410. [PMID: 30296865 DOI: 10.1177/0300060518802923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Luo S, Xu J, Xiong W, Li J, Luo L, Zheng Y, Zeng H, Liu Y, Yang L, Wu Z, Yang X, Wang W. Feasibility and efficacy of transthoracic single-port assisted laparoscopic esophagogastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction. Ann Transl Med 2021;9:1540. [PMID: 34790746 DOI: 10.21037/atm-21-4574] [Reference Citation Analysis]
11 Mokdad AA, Ali A, Yopp AC, Polanco PM, Nassour I, Mansour JC, Choti MA, Minter RM, Wang SC, Porembka MR. Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study. Cancer 2018;124:1122-31. [PMID: 29211302 DOI: 10.1002/cncr.31179] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
12 Potrc S, Ivanecz A, Krebs B, Marolt U, Iljevec B, Jagric T. Outcomes of the Surgical Treatment for Adenocarcinoma of the Cardia - Single Institution Experience. Radiol Oncol 2018;52:65-74. [PMID: 29520207 DOI: 10.1515/raon-2017-0039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]